Germany· DE-A57-8d99edf7a51311c5
Riopan Magen Tabletten Mint
A magaldrate product containing magaldrate anhydrous, registered in Germany by Dr. Kade Pharmazeutische Fabrik Gmbh. The same ATC class is registered in 6 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Magaldrate is registered in 6 of 19 countries.
Countries holding a registration under ATC A02AD02 (magaldrate), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 4 of them publish a price we can compare per daily dose
Magaldrate · ATC A02AD02
6 / 19 countries
- Belgiumprice
- Finlandprice
- Germany
- Italyprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of magaldrate costs, country by country.
Normalised to the WHO defined daily dose (3.2 g), the median price runs from $0.54 in Italy to $1.43 in Switzerland — a ×2.6 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Magaldrate · price per daily dose (3.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.43
- IT Italy$0.54
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Magaldrate Anhydrous
- Manufacturer
- Dr. Kade Pharmazeutische Fabrik Gmbh
- Country
- Germany (DE)
- ATC code
- A02AD02
- ATC class
- Magaldrate
- Defined daily dose
- 3.2 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
223 interactions on record for magaldrate.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Magaldrate · interactions on record
223 records
- 8 severe
- 106 moderate
- 93 minor
Most severe, free to view
- RaltegravirJ05AJ01severe
- DolutegravirJ05AJ03severe
- RaltegravirJ05AX08severe
- DolutegravirJ05AX12severe
16 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Magaldrate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyGADRALNEOPHARMED GENTILI S.P.A.
- SwitzerlandRiopan 800 mg, TablettenTakeda Pharma AG
- BelgiumGastricalm 400 mgNovum Pharma
- SpainBEMOLAN 2000 mg GEL ORALTakeda Farmaceutica Espana S.A.
- United KingdomBisodol Extra tabletsForest Laboratories UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Austria · Riopan
- Belgium · Riopan
- Spain · Bemolan, Magión
- Greece · Riopan
- Italy · Gadral, Magaldrato Doc
- Luxembourg · Riopan
- Portugal · Riopan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/da5457be-b929-4b75-a64a-53455f36f460 GET /v1/drugs/da5457be-b929-4b75-a64a-53455f36f460?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Magaldrate Anhydrous",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about magaldrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.